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In the present issue of Critical Care, Granja and colleagues
present their findings regarding the quality of life of patients
who survived an intensive care unit (ICU) episode of care for
severe sepsis compared with other ICU survivors [1]. They
used the EQ-5D instrument to measure quality of life
6 months after discharge and found that quality of life was
generally poor and not noticeably different between sepsis
survivors and other ICU survivors. Several points come to
mind when reading this work.
The authors are to be commended for the rigor with which
they have followed up their ICU patients. This is only one of
several studies from this group, and their findings have
further stressed that discharge from the ICU alive is not
necessarily the same thing as an immediate return to full
health and happiness [2–4]. As intensive care grows to
become a larger part of acute care health delivery, it is crucial
to understand the value of our care and the outcomes of our
patients on a human and social dimension. For example, 2%
of the entire US adult population now cycles through
intensive care every year [5]. At this volume, any unwanted
lingering consequences of either critical illness or ICU
interventions will be writ large across the entire public health
of a given community. It is therefore our responsibility, as the
guardians of critical illness and as the providers of critical
care, to fully delineate, measure, interrogate and, ultimately,
mitigate all unwanted consequences of the ‘ICU diseases’.
The first step, obviously, is to not be satisfied simply with
getting the patient out of the ICU alive, but to know more
about what happens subsequently and why [6].
The authors of the current study showed that little more than
one-half of their patients had returned to usual activities at
6 months after discharge, and one-third to one-half were in
worse health than one year earlier. These findings are not
uncommon for ICU follow-up studies, and they definitely
suggest ICU survivors are different from the general public.
However, patients who come into the ICU are not randomly
selected from the general population in the first place. It is
difficult to know whether these patients have any new
decrement in quality of life and health status, or whether their
poor outcomes are part of inherently poor health status
streams that were already in decline prior to ICU admission.
Some studies, either by limiting inclusion to previously healthy
subjects or by reporting results separately for previously
healthy subjects, have certainly suggested that protracted
intensive care for an acute illness does result in new, sustained
decrements in quality of life and in health status [7–9]. It would
be interesting to know whether the one-third of patients in this
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Abstract
Granja and colleagues have helped us by showing that long-term follow-up is feasible and by trying to
tease out whether select intensive care unit patient populations are at particular risk of adverse
outcomes. This work gives us clues for future investigations which will hopefully interrogate further the
potential mechanisms of action that underlie poor long-term outcomes. In the meantime, we can hope
that this quality of follow-up will move from the research arena to become a part of routine clinical care.
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study who were previously healthy fared similarly. Regardless,
it seems probable that, in at least some portion of patients,
there is a new decrement. Our efforts should now therefore
begin to move away from simply documenting this problem to
better understanding why it happens.
The current study suggests that there was no obvious
difference between septic ICU patients and nonseptic ICU
patients. While this is helpful, there were important
differences between the two groups, which may preclude
drawing strong inferences. For example, many of the control
patients were admitted postoperatively, while the septic
cases were predominantly medical patients admitted with a
primary problem of infection and organ dysfunction. In
addition, when one posits ‘why’ sepsis may have lingering
consequences, the various debilitating effects of the
associated ‘cytokine storm’ are strong candidates. Yet many
of the ICU controls may have similarly suffered profound
inflammatory insults, and so some of the potential
mechanisms for poor long-term health and quality of life may
have been present in both the cases and the controls.
So how do we tease this out? Fundamentally, we have to
begin articulating and testing specific hypotheses about why
health status and quality of life may be poor post ICU
discharge. We must subtract the ‘background noise’ of pre-
existing conditions, and must specifically explore both the
potential mechanisms of action for new decrements and the
numerous interactions between different downstream
outcomes. For example, how rapidly do we lose lean muscle
mass when sick and ‘cytokine-emic’ in the ICU? How
effectively do we replete lean muscle mass during
convalescence? How often does loss of lean muscle mass
impair critical physical functions, such as getting in and out of
bed or a chair? How often, and in whom, does change in
physical capability domino into impaired mental and mood
status? Which ICU patient groups are most susceptible to
any of these events, and who is most susceptible to the entire
chain of events? Similar questions might be asked about
mood, neurocognition, and organ system function for all the
‘classic’ organ dysfunction syndromes of critical illness.
Finally, although I think greater insight into the mechanisms of
action underlying poor long-term outcomes will be extremely
helpful, I do not propose that we be paralyzed clinically in the
meantime. Jones and colleagues recently showed that a
relatively simple intervention aimed at promoting improved
rehabilitation may improve recovery from critical illness [10].
Other service delivery packages, without specific knowledge
of the mechanism of action, have also proven helpful in
analogous groups of patients, such as survivors of traumatic
brain injury or stroke, and frail geriatric populations [11–13].
Even outside the clinical trials, the simple act of bringing our
knowledge and expertise to the ICU survivor once she has left
the ICU may enhance the quality of care for that patient [14]
and may provide important feedback to the ICU practitioner.
In summary, Granja and colleagues have helped us by
showing that long-term follow-up is feasible and by trying to
tease out whether select ICU patient populations are at
particular risk of adverse outcomes. This work gives us clues
for future investigations that will hopefully interrogate further
the potential mechanisms of action that underlie poor long-
term outcomes. In the meantime, we can hope that this
quality of follow-up will move from the research arena to
become a part of routine clinical care.
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